Preoperative alpha blockade for normotensive pheochromocytoma
- 1 December 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hypertension
- Vol. 29 (12), 2429-2432
- https://doi.org/10.1097/hjh.0b013e32834d24d9
Abstract
Objective To compare the intraoperative hemodynamics in normotensive pheochromocytoma patients undergoing tumor resection between those with α-blockade preparation, preoperatively, and those without it. Methods From January 2003 to July 2011, patients with adrenal incidentaloma, which was highly suspected as normotensive pheochromocytoma, were divided into two groups. Group 1 recieved α1-blockade doxazosin before adrenalectomy. Group 2 received no α-adrenoceptor, preoperatively. Data regarding the intraoperative hemodynamics was collected. These include peak/nadir blood pressure (BP) and heart rate, vasoactive medication and fluid infusion. Results Fifty-nine cases of pheochromocytoma were confirmed by histopathology examination: 38 in group 1 and 21 in group 2. No differences were found in the preoperative demographics, comorbidities, BP and anesthesia. Intraoperative BP and heart rate showed no difference between these two groups. Intraoperative use of nitroglycerin (P < 0.001), norepinephrine (P < 0.001), phentolamine (P < 0.001) and colloid fluid (P = 0.008) was significantly greater in group 1 with doxazosin. Conclusion Preoperative α1-adrenoceptor antagonist has no benefit in maintaining intraoperative hemodynamic stability in patients with normotensive pheochromocytoma. It may increase the use of vasoactive drugs and colloid infusion.Keywords
This publication has 17 references indexed in Scilit:
- Reply by the AuthorsUrology, 2010
- Comparison of Two Preoperative Medical Management Strategies for Laparoscopic Resection of PheochromocytomaUrology, 2010
- The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine TumorsPancreas, 2010
- Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytomaEndocrine, 2010
- Doxazosin: safety and efficacy in the treatment of resistant arterial hypertensionBlood Pressure, 2009
- Pheochromocytoma: State-of-the-Art and Future ProspectsEndocrine Reviews, 2003
- Management of the Clinically Inapparent Adrenal Mass (“Incidentaloma”)Annals of Internal Medicine, 2003
- Advances in the Diagnosis and Treatment of PheochromocytomaArchives of Surgery, 1988
- Clinical pharmacological studies with doxazosin.British Journal of Clinical Pharmacology, 1986
- The alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology.British Journal of Clinical Pharmacology, 1986